MHE Staff

Early research shows the CD40L antibody tegoprubart is able to reduce insulin dependence in patients with type 1 diabetes after islet transplants.

Medicare patients are more likely to receive aflibercept 2 mg over other anti-VEGF agents compared with commercially insured patients.

After expansion of Medicaid, there was a significant decrease in the low-income population with no healthcare coverage.

Patients with HIV who receive Cabenuva injections are more closely followed by physicians to assess the risk of cardiovascular, liver and kidney disease.

The survey also found that flexible and virtual appointments, as well as transportation support, were helpful while on injection long-acting PrEP.

The higher dose led to a more rapid decline in an important marker of neurodegeneration, according to a Biogen news release announcing the results.

Jill Zouzoulas, M.D., of Tryon Medical Partners in Charlotte, North Carolina, and Jennifer Seminerio, M.D., of University of Southern Florida Health in Tampa, Florida, discussed the biologics and the pros and cons of the intravenous and subcutaneous delivery methods in Managed Healthcare Executive’s K-Cast video series.

Arwen Podesta, M.D., discussed prescription digital therapeutics for people with mental health and substance abuse conditions in a Managed Healthcare Executive K-Cast video series. Podesta is a New Orleans-based board-certified adult psychiatrist with subspecializations in addiction medicine, forensic psychiatry and integrative medicine.

Paul W. Noble, M.D., of Cedars-Sinai in Los Angeles, and Paul Frohna, M.D., Ph.D., of Endeavor BioMedicines, discussed the symptoms, epidemiology diagnosis and treatment of idiopathic pulmonary fibrosis (IPF) in a Managed Healthcare Executive K-Cast video series.

Sean M. Oser, M.D., M.P.H., an associate professor in the Department of Family Medicine at the University of Colorado School of Medicine, discussed diabetes management and quality measures in a Managed Healthcare Executive K-Cast video series.

Data from the DEVOTE study suggest that 50-milligram doses are safe and effective.

Researchers surveyed 201 men who have sex with men and transgender men from 17 clinics who began long-acting cabotegravir to prevent infection with HIV.

Lotilaner ophthalmic solution 0.25% drops are administered as twice daily for six weeks. Other ways of treating Demodex blepharitis manage symptoms, not the root cause, and are of indeterminate length.

Here’s what you missed this week on Managed Healthcare Executive.

A separate trial is ongoing of Sunlenca as pre-exposure prophylaxis (PrEP) for men with topline data expected in late 2024 or early 2025.

Priority Health is acquiring 52,000-member Physicians Health Plan of Northern Indiana.

Public health, artificial intelligence and GLP-1s are on the agenda of the June 11-13 meeting in Las Vegas.

PDTs represent a shift in how treatment is delivered

Type 1 diabetes is an autoimmune disease that affects more than 2 million Americans.

An administration change in November could see the return of closed borders or increased protections for immigrants.

Undocumented individuals are ineligible for the Affordable Care Act (ACA) or federally funded Medicaid, but some states offer state-sponsored coverage for certain immigration statuses, such as Temporary Protected Status.

Immigrant children need a variety of resources when they come to the United States.

Company officials said a challenging reimbursement environment and escalating operating costs created a lack of profitability for the business.

In a discussion with Managed Healthcare Executive, Cate Lockhart, Pharm.D., Ph.D., executive director, Biologics and Biosimilars Collective Intelligence Consortium, talks about the disappointment surrounding the uptake of Humira biosimilars.

In a discussion with Managed Healthcare Executive, Cate Lockhart, Pharm.D., Ph.D., executive director, Biologics and Biosimilars Collective Intelligence Consortium, talks about whether or not she favors ending interchangeability designation for biosimilars.

Walgreens is expanding its specialty pharmacy services and renaming AllianceRx Walgreens Pharmacy as Walgreens Specialty Pharmacy.

Joseph Zabinski, PhD, MEM, vice president, head of commercial strategy and AI, OM1, chatted with MHE editors on the significance of patient acceptance in AI adoption in healthcare, overall and in the dermatology space, stressing trust and transparency.

This week, the annual meeting of the Academy of Managed Care Pharmacy (AMCP) will bring 3,400 pharmacy, payers and industry leaders to New Orleans.

Datopotamab deruxtecan, which is being reviewed to treat adults with HR-positive, HER2-negative breast cancer, has an FDA target date in the first quarter of 2025. Datopotamab deruxtecan also is under FDA review for non-small cell lung cancer.

We need your views! Help us help you.